Fixed-dose antiretroviral combinations in children living with human immunodeficiency virus type 1 (HIV-1): a systematic review

J Chemother. 2023 Dec 28:1-15. doi: 10.1080/1120009X.2023.2297095. Online ahead of print.ABSTRACTFixed-Dose antiretroviral Combinations (FDCs) are the most used drug regimes in adult patients with human-immunodeficiency virus 1 infection, since they increase adherence to antiretroviral therapy and enable good quality of life. The European AIDS Clinical Society guidelines recommend the use of FDCs in paediatrics. However, the use of FDCs in paediatric population is restricted since studies in children and adolescents are mostly conducted in small sample sizes and are heterogeneous in settings and design. This systematic review aims to summarize the current knowledge about the use of FDCs in paediatric population, highlighting the relevant outcomes regarding efficacy and effectiveness, adherence, safety, and adverse events of these regimens.PMID:38153234 | DOI:10.1080/1120009X.2023.2297095
Source: Journal of Chemotherapy - Category: Cancer & Oncology Authors: Source Type: research